These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8098865)

  • 1. Modulation of P-glycoprotein-mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells.
    Efferth T; Volm M
    Oncology; 1993; 50(4):303-8. PubMed ID: 8098865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4.
    Efferth T; Lathan B; Volm M
    Br J Cancer; 1991 Jul; 64(1):87-9. PubMed ID: 1677260
    [No Abstract]   [Full Text] [Related]  

  • 3. [Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16, and their synergistic modulation of multidrug resistance].
    Naito M; Tsuruo T
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):395-402. PubMed ID: 7906507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein.
    Schinkel AH; Arceci RJ; Smit JJ; Wagenaar E; Baas F; Dollé M; Tsuruo T; Mechetner EB; Roninson IB; Borst P
    Int J Cancer; 1993 Sep; 55(3):478-84. PubMed ID: 8104165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16.
    Naito M; Tsuge H; Kuroko C; Tomida A; Tsuruo T
    Jpn J Cancer Res; 1993 May; 84(5):489-92. PubMed ID: 8100562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody.
    Dinota A; Tazzari PL; Michieli M; Visani G; Gobbi M; Bontadini A; Tassi C; Fanin R; Damiani D; Grandi M
    Cancer Res; 1990 Jul; 50(14):4291-4. PubMed ID: 1694719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines.
    Chu TM; Kawinski E; Lin TH
    Hybridoma; 1993 Aug; 12(4):417-29. PubMed ID: 7503940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal delivery of antisense oligodeoxynucleotides. Application to the inhibition of the multidrug resistance in cancer cells.
    Thierry AR; Dritschilo A
    Ann N Y Acad Sci; 1992 Oct; 660():300-2. PubMed ID: 1364094
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-directed therapy of multidrug-resistant tumor cells.
    Efferth T; Volm M
    Med Oncol Tumor Pharmacother; 1992; 9(1):11-9. PubMed ID: 1285219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.
    Pearson JW; Fogler WE; Volker K; Usui N; Goldenberg SK; Gruys E; Riggs CW; Komschlies K; Wiltrout RH; Tsuruo T
    J Natl Cancer Inst; 1991 Oct; 83(19):1386-91. PubMed ID: 1681110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of P-glycoprotein-mediated multidrug resistance in a doxorubicin-resistant subline of the human lymphoblastoid cell line CCRF-CEM by phosphorothioate antisense oligonucleotides.
    Dassow H; Lassner D; Remke H; Preiss R
    Int J Clin Pharmacol Ther; 1998 Feb; 36(2):93-6. PubMed ID: 9520155
    [No Abstract]   [Full Text] [Related]  

  • 13. Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides.
    Thierry AR; Rahman A; Dritschilo A
    Biochem Biophys Res Commun; 1993 Feb; 190(3):952-60. PubMed ID: 8094959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176).
    Robey RW; Zhan Z; Piekarz RL; Kayastha GL; Fojo T; Bates SE
    Clin Cancer Res; 2006 Mar; 12(5):1547-55. PubMed ID: 16533780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.
    Cordon-Cardo C; O'Brien JP; Boccia J; Casals D; Bertino JR; Melamed MR
    J Histochem Cytochem; 1990 Sep; 38(9):1277-87. PubMed ID: 1974900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumvention of multi-drug resistance in human kidney and kidney carcinoma in vitro.
    Volm M; Pommerenke EW; Efferth T; Löhrke H; Mattern J
    Cancer; 1991 May; 67(10):2484-9. PubMed ID: 1673084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues.
    Tóth K; Vaughan MM; Slocum HK; Arredondo MA; Takita H; Baker RM; Rustum YM
    Am J Pathol; 1994 Feb; 144(2):227-36. PubMed ID: 7508682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circumvention of multidrug resistance mediated by P-170 glycoprotein using calcium antagonists in primary human renal cell carcinoma.
    Mickisch GH; Kössig J; Tschada RK; Keilhauer G; Schlick E; Alken PM
    Urol Int; 1991; 47(3):118-25. PubMed ID: 1685271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies.
    Schinkel AH; Roelofs EM; Borst P
    Cancer Res; 1991 May; 51(10):2628-35. PubMed ID: 1673638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides.
    Gnarra JR; Dressler GR
    Cancer Res; 1995 Sep; 55(18):4092-8. PubMed ID: 7664285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.